Computational multi-omics modelling identifies TOP2A as a central prognostic biomarker and therapeutic target in renal cell carcinoma
Archives of Biochemistry and Biophysics · 2026-08 · 782 · 110865
DOI: 10.1016/j.abb.2026.110865 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026-08. Verfasst von Shahid Ullah Khan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Dubai Medical College for Girls, Dubai Medical University, Dubai, 19099, United Arab Emirates; Department of Anima…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, DNA Topoisomerases, Type II, Kidney Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
This study systematically investigates the clinicopathological and molecular significance and tumorigenic functions of TOP2A in the kidney cancer subtypes KIRC, KIRP, and KICH through integrative bioinformatics analyses utilizing TCGA and a suite of different databases, including cBioPortal, UALCAN, GEPIA, TIMER, KM Plotter, TISIDB, OncoDB, ENCORI, MEXPRESS, String, GeneMANIA, and the Human Protein Atlas etc. TOP2A expression was found to be significantly upregulated across a range of clinical contexts, including pathological stage, histological subtype, tumor grade, and lymph node involvement. Aggressive tumor characteristics and poor patient outcomes were consistently linked to elevated TOP2A levels. Frequent changes at the TOP2A locus were found by genomic profiling, primarily in the form of gene amplifications and mutations. Correlation analysis corroborated TOP2A involvement in abnormal cell cycle regulation by showing a strong positive association between TOP2A and CDK family members. TOP2A expression is strongly correlated to various immune cell types and immunomodulatory variables, according to additional investigation of immune infiltration, suggesting a potential role in forming the tumor immune microenvironment. Furthermore, pathway enrichment analysis revealed that TOP2A expression levels influence the activation or suppression of multiple cancer-related signaling pathways. Higher TOP2A expression is associated with enhanced sensitivity to certain anticancer treatments, according to drug sensitivity analysis based on GDSC data and Pearson correlation. Furthermore, the notion that TOP2A plays a key role in oncogenic networks was supported by protein-protein interaction network analysis. Overall, these findings imply that TOP2A may be a possible therapeutic target in KIRC, KIRP, and KICH as well as a helpful predictive biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Dubai Medical College for Girls, Dubai Medical University, Dubai, 19099, United Arab Emirates; Department of Animal Science, Faculty of Animal and Agricultural Sciences, Universitas Di…
- Biomedical Nano Center, School of Life Science, Inner Mongolia Agricultural University, Hohhot, 010018, China.
- Department of Transfusion Medicine and Clinical Microbiology, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, 10330, Thailand; Stem Cell and Cancer Research, Semarang, 50223, Indonesia.
- Inner Mongolia Key Laboratory for Molecular Regulation of the Cell, School of Life Sciences, Inner Mongolia University, Hohhot, 010020, China.
- Department of Chemical Pathology, School of Medical Science, Health Campus, University Sains Malaysia, Kota Baru, Kelantan, 16150, Malaysia.
- Department of Animal Science, Faculty of Animal and Agricultural Sciences, Universitas Diponegoro., Jl. Prof. Jacub Rais, Tembalang, Semarang, Central Java, 50275, Indonesia; Food Research for Safety, Security, and Sust…
Zitieren
APA
Khan, S. U., Khan, A. J., Khan, F. A., Man, S., Ali, A., Pandupuspitasari, N. S., Widiastuti, E., Nauman, M., & Rehman, K. U. (2026). Computational multi-omics modelling identifies TOP2A as a central prognostic biomarker and therapeutic target in renal cell carcinoma. Archives of Biochemistry and Biophysics, 782, 110865. https://doi.org/10.1016/j.abb.2026.110865
Vancouver
Khan SU, Khan AJ, Khan FA, Man S, Ali A, Pandupuspitasari NS, et al. Computational multi-omics modelling identifies TOP2A as a central prognostic biomarker and therapeutic target in renal cell carcinoma. Archives of Biochemistry and Biophysics. 2026;782:110865. doi:10.1016/j.abb.2026.110865
BibTeX
@article{Khan2026,
author = {Khan, Shahid Ullah and Khan, Abdul Jamil and Khan, Faheem Ahmed and Man, Shad and Ali, Akbar and Pandupuspitasari, Nuruliarizki Shinta and Widiastuti, Endang and Nauman, Muhammad and Rehman, Khalil Ur},
title = {Computational multi-omics modelling identifies TOP2A as a central prognostic biomarker and therapeutic target in renal cell carcinoma},
journal = {Archives of Biochemistry and Biophysics},
year = {2026},
volume = {782},
pages = {110865},
doi = {10.1016/j.abb.2026.110865}
}
EUVIMED